Long-term hepatitis B and liver outcomes among adults taking tenofovir-containing antiretroviral therapy for HBV/HIV coinfection in Zambia

By sjmartinez • November 24, 2023

Vinikoor MJ, Hamusonde K, Muula G, Asombang M, Riebensahm C, Chitundu H, Sunkuntu-Sichizya V, Bhattacharya D, Sinkala E, Lauer G, Chung R, Mbewe W, Egger M, Bosomprah S, Wandeler G. Long-term hepatitis B and liver outcomes among adults taking tenofovir-containing antiretroviral therapy for HBV/HIV coinfection in Zambia. Clin Infect Dis. 2023 Nov 24:ciad654. doi: 10.1093/cid/ciad654. Epub ahead of print. PMID: 37997691.

Tags: Antiviral Therapy, hepatitis B, Hepatocellular carcinoma, HIV/AIDS, Infectious Diseases, liver fibrosis, Publications, Veterans Administration

Related Posts

Access to HIV treatment during community-wide flooding: Experiences of people living with HIV and health care workers in Malawi, a mixed methods study

Mphande M, Paneno R, Robson I, Phiri K, Cornell M, van Oosterhout JJ, Eisenman DP, Njala J, Phiri S, Dovel K. Access to HIV treatment[...]

Implementation Does Not Occur in a Vacuum: Sustaining a Comprehensive and Global Vision for HIV Research

Gianella S, Lauring A, Paredes R, Croda J, Andes D, Uhlemann AC, Chew K, Stephenson KE, Lewnard JA, John ARO, Leung DT, Clancy CJ, Chu[...]

Recurrent mutations in the stress regulator Cap1 reveal a trade-off between azole resistance and oxidative stress response in Candida albicans

Zhou X, Hilk A, Solis NV, Scott N, Zajac C, Filler SG, Selmecki A. Recurrent mutations in the stress regulator Cap1 reveal a trade-off between[...]